Study Start-Up & Site Feasibility

Clinical Study Start-Up & Feasibility for Faster Site Activation

Accelerating Study Start-Up: From Site Identification to Site Activation

Clinical study start-up is one of the most significant drivers of clinical trial timelines and costs. Delays in site selection, regulatory submissions, contract negotiations, and site activation can impact both study delivery and patient recruitment. Allucent integrates site feasibility, regulatory strategy, clinical study start-up, and site engagement into a coordinated approach designed to accelerate clinical site activation, reduce operational risk, and improve patient recruitment predictability and study success.

Powered by Allucent’s proprietary country intelligence database, we leverage AI-enabled analytics, regulatory intelligence, and country-level insights to support smarter planning, faster decision-making, and optimized study start-up strategies. Through established relationships with high-performing research sites and Allucent’s IGNITE™ Site Network, we help sponsors activate the right sites, access diverse patient populations, and support consistent study delivery across global geographies.

The fast pace and constant whirlwind within study start-up requires adaptation as well as identifying innovative solutions to navigate this environment. Robust planning and solid partnerships with sites are key for accelerating study-start-up and bringing medicines to patients.

Christine Khoza

Global Head, Study Start-Up & Site Intelligence

Other Areas of Expertise

IGNITE Site Network

Patient Recruitment & Retention

Therapeutic Expertise

Clinical Development

Additional Resources

EU CTR Submission for Phase I/II Oncology Clinical Trial

Case Studies

Achieving EU CTR Submission in Under 3 Weeks: An Oncology Case Study

Learn More

Navigating CAR T Regulatory Challenges Strategy for FDA Approval

Blogs

Tackle CAR T Regulatory Challenges: Strategies for FDA Approval

Learn More

Blogs

FDA’s CNPV Program: What Biopharma Needs to Know

Learn More

Frequently Asked Questions About Clinical Trial Start-Up & Site Feasibility

1 What is clinical trial site feasibility? +

Site feasibility is the process of assessing whether a research site has what it takes to support a specific study, looking at patient population access, therapeutic expertise, historical recruitment performance, standard of care, and overall operational capability.

2 What does a multifactorial feasibility assessment cover? +

A multifactorial feasibility assessment combines epidemiology, competitive trial activity, historical site performance, therapeutic expertise, operational readiness, protocol fit, regulatory timelines, and patient access insights. Assessing these factors together helps sponsors select sites with the greatest potential to activate quickly, recruit predictably, and deliver high-quality study execution.

3 Why is early site engagement part of the feasibility process? +

Bringing in principal investigators and sites during feasibility, rather than after selection, gives teams the opportunity to pressure-test study assumptions, spot operational challenges early, and build stronger confidence in patient accrual targets and timelines before activation begins.

4 What is clinical study start-up? +

Clinical study start-up covers all the activities needed to prepare a clinical trial for execution, including site selection, regulatory submissions, contract and budget negotiations, and site activation. It is one of the key cost drivers in any clinical program.

5 Why are delays common in clinical trial start-up? +

Start-up involves multiple time-sensitive deliverables across regulatory, legal, and operational workstreams. The complexity and interdependency of these activities makes delays frequent and costly without structured planning and clear ownership at each stage.

6 How can clinical study start-up timelines be accelerated? +

Timelines can be shortened through data-driven site selection, strategic submission planning, streamlined contract and budget negotiations, and consistent site engagement throughout the start-up period to ensure patient recruitment readiness.

Watch Our Corporate Video

Clinical Study Start-Up & Feasibility for Faster Site Activation

Accelerating Study Start-Up: From Site Identification to Site Activation